Talk to a doctor or pharmacist before taking Trimetazidine Hydrochloride tablet. This medicinal product is generally not recommended during breast-feeding.
This medicinal product is not a curative treatment for angina attacks, nor an initial treatment for unstable angina pectoris. It is not a treatment for myocardial infarction. In the event of an angina attack, inform a doctor. Tests may be required and treatment may possibly be modified. This medicine can cause or worsen symptoms such as trembling, rigid posture, slow movements and a shuffling, unbalanced walk, especially in elderly patients, which should be investigated and reported to a doctor who could reassess the treatment. Falls may occur following a drop in blood pressure or a loss of balance.
Caution should be exercised when prescribing Trimetazidine to patients in whom an increased exposure is expected: moderate renal impairment; elderly patients older than 75 years old.
Driving and using machines: This medicine may make the patient feel dizzy and drowsy that may affect the ability to drive or use machinery.
Use in Children: Children and adolescents: Trimetazidine Hydrochloride tablet is not recommended in children aged below 18 years.
Other Services
Country
Account